Transparency in reporting of phase 3 cancer clinical trial results

Acta Oncol. 2021 Feb;60(2):191-194. doi: 10.1080/0284186X.2020.1856410. Epub 2020 Dec 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • Neoplasms* / therapy
  • Research Design*